179 related articles for article (PubMed ID: 25625287)
1. Long‑term exposure to leptin enhances the growth of prostate cancer cells.
Noda T; Kikugawa T; Tanji N; Miura N; Asai S; Higashiyama S; Yokoyama M
Int J Oncol; 2015 Apr; 46(4):1535-42. PubMed ID: 25625287
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression.
Tan Y; Wang L; Du Y; Liu X; Chen Z; Weng X; Guo J; Chen H; Wang M; Wang X
Int J Oncol; 2018 Dec; 53(6):2503-2517. PubMed ID: 30272279
[TBL] [Abstract][Full Text] [Related]
3. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion.
Zhang H; Pan Y; Zheng L; Choe C; Lindgren B; Jensen ED; Westendorf JJ; Cheng L; Huang H
Cancer Res; 2011 May; 71(9):3257-67. PubMed ID: 21505104
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
5. A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells.
Liu P; Li S; Gan L; Kao TP; Huang H
Cancer Res; 2008 Dec; 68(24):10290-9. PubMed ID: 19074897
[TBL] [Abstract][Full Text] [Related]
6. MHY-449, a novel dihydrobenzofuro[4,5-b][1,8] naphthyridin-6-one derivative, induces apoptotic cell death through modulation of Akt/FoxO1 and ERK signaling in PC3 human prostate cancer cells.
Lee SH; Kang YJ; Sung B; Kim DH; Lim HS; Kim HR; Kim SJ; Yoon JH; Moon HR; Chung HY; Kim ND
Int J Oncol; 2014 Mar; 44(3):905-11. PubMed ID: 24424889
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1.
Lu H; Liu P; Pan Y; Huang H
Neoplasia; 2011 Sep; 13(9):854-63. PubMed ID: 21969818
[TBL] [Abstract][Full Text] [Related]
8. CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor.
Liu P; Kao TP; Huang H
Oncogene; 2008 Aug; 27(34):4733-44. PubMed ID: 18408765
[TBL] [Abstract][Full Text] [Related]
9. The Akt/FoxO1/p27 pathway mediates the proliferative action of liraglutide in β cells.
Fang D; Huang Z; Guan H; Liu J; Yao B; Xiao H; Li Y
Mol Med Rep; 2012 Jan; 5(1):233-8. PubMed ID: 21964769
[TBL] [Abstract][Full Text] [Related]
10. A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation.
Mahajan SG; Fender AC; Meyer-Kirchrath J; Kurt M; Barth M; Sagban TA; Fischer JW; Schrör K; Hohlfeld T; Rauch BH
Thromb Haemost; 2012 Jul; 108(1):148-58. PubMed ID: 22552808
[TBL] [Abstract][Full Text] [Related]
11. Expression and localization of FOXO1 in non-small cell lung cancer.
Maekawa T; Maniwa Y; Doi T; Nishio W; Yoshimura M; Ohbayashi C; Hayashi Y; Okita Y
Oncol Rep; 2009 Jul; 22(1):57-64. PubMed ID: 19513505
[TBL] [Abstract][Full Text] [Related]
12. Leptin signaling and apoptotic effects in human prostate cancer cell lines.
Samuel-Mendelsohn S; Inbar M; Weiss-Messer E; Niv-Spector L; Gertler A; Barkey RJ
Prostate; 2011 Jun; 71(9):929-45. PubMed ID: 21541970
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-223 regulates FOXO1 expression and cell proliferation.
Wu L; Li H; Jia CY; Cheng W; Yu M; Peng M; Zhu Y; Zhao Q; Dong YW; Shao K; Wu A; Wu XZ
FEBS Lett; 2012 Apr; 586(7):1038-43. PubMed ID: 22569260
[TBL] [Abstract][Full Text] [Related]
14. Differential response of glioma cells to FOXO1-directed therapy.
Lau CJ; Koty Z; Nalbantoglu J
Cancer Res; 2009 Jul; 69(13):5433-40. PubMed ID: 19549905
[TBL] [Abstract][Full Text] [Related]
15. CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage.
Huang H; Regan KM; Lou Z; Chen J; Tindall DJ
Science; 2006 Oct; 314(5797):294-7. PubMed ID: 17038621
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro studies of anticancer actions of alpha-TEA for human prostate cancer cells.
Jia L; Yu W; Wang P; Sanders BG; Kline K
Prostate; 2008 Jun; 68(8):849-60. PubMed ID: 18324647
[TBL] [Abstract][Full Text] [Related]
17. [Effect of downregulation of prostate cancer antigen-1 expression on malignant biological behavior of prostate cancer LNCaP cells].
Liu BQ; Wang YK; Wu YD; Wei JX; Li X
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):828-32. PubMed ID: 24447480
[TBL] [Abstract][Full Text] [Related]
18. Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT2.
Huang Y; Jin Q; Su M; Ji F; Wang N; Zhong C; Jiang Y; Liu Y; Zhang Z; Yang J; Wei L; Chen T; Li B
Cell Oncol (Dordr); 2017 Dec; 40(6):537-547. PubMed ID: 28770546
[TBL] [Abstract][Full Text] [Related]
19. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1.
Wu Z; Sun H; Zeng W; He J; Mao X
PLoS One; 2012; 7(9):e45825. PubMed ID: 23029264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
